Last Updated: May 10, 2026

Profile for Slovenia Patent: 3386518


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 3386518

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Dec 7, 2036 Genzyme Corp QFITLIA fitusiran sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Slovenia Patent SI3386518: Scope, Claims, and Patent Landscape

Last updated: February 20, 2026

What does the patent SI3386518 cover?

Patent SI3386518, filed in Slovenia, pertains to a pharmaceutical compound or formulation. The specific chemical composition and therapeutic use are central, although full details require access to the official patent document. Based on typical patent filings, it likely claims novel compounds, methods of synthesis, and therapeutic applications.

Composition and Claim Scope

  • Primary Claims: Usually cover a novel chemical entity or a combination of compounds with therapeutic efficacy.
  • Method Claims: Cover methods of manufacturing or administering the drug.
  • Use Claims: Cover specific medical indications, such as treatment of particular diseases.

Exact claims are cited as the basis for enforceability and scope. They determine infringement boundaries and define patent protections.

How broad are the claims?

The breadth depends on claim language:

  • Product Claims: Cover specific compounds with structural definitions, often including chemical formulae.
  • Method Claims: Cover particular processes, such as synthesis routes or modes of administration.
  • Use Claims: Cover functions, such as treatment of specific conditions.

If claims are broad, they may inhibit competitors from developing similar compounds. Narrow claims restrict the patentee's rights but are easier to defend.

Patent landscape and related filings

Geographical coverage

  • The patent is registered in Slovenia. European patents can extend protection across EU member states via the European Patent Convention, if granted.
  • No information suggests PCT or international filings; completeness depends on regional filings.

Competitor patents

  • Similar compounds may be covered by patents in other jurisdictions like EP, US, or WO applications.
  • The landscape likely includes patents targeting specific chemical structures or therapeutic uses within the same class.

Timeline

  • Filing date: Typically, patent applications are filed years prior to grant.
  • Publication: Usually 18 months post-filing.
  • Grant date: Official approval date, after examination.

For SI3386518, specific dates are needed for full landscape analysis, which inform freedom-to-operate assessments.

Precedent and patent family analysis

  • Patent families extend protection to multiple jurisdictions.
  • Related patents might include previously filed applications for the same invention or improvements.
  • Analyzing family members aids in understanding the innovator’s scope and competitive positioning.

Enforcement and patent strength

  • Patent validity depends on novelty, inventive step, and industrial application.
  • Claims must be supported by disclosure.
  • Enforcement is jurisdiction-specific; Slovenia’s patent office administers the patent.

Strategic implications

  • Broad claims may block competitors but are vulnerable to challenges.
  • Narrow claims provide strength within specific niches.
  • Patents in key markets like the EU, US, or emerging countries expand protection.

Summary of key points

Aspect Details
Scope Likely includes chemical composition, synthesis methods, therapeutic use
Claims Comprise product, method, and use claims, with actual breadth pending document review
Landscape Focused on Slovenia, potentially extendable via European patents
Competitors Patent landscape features similar compounds and indications worldwide
Timeline Filing, publication, and grant dates influence patent maturity and competition

Key takeaways

  • Exact claim language and scope depend on the official granted patent document.
  • The patent likely covers a novel drug compound, method, or use with specific claims.
  • A comparative assessment of claims and expired patents is necessary to identify freedom-to-operate.
  • Global patent families and related filings can strengthen or constrain market protection.
  • Ongoing patent examination and litigation, if any, influence enforceability.

FAQs

Q1: How can the scope of patent SI3386518 affect market entry?
A1: Broader claims can block competitors from developing similar drugs, while narrower claims may allow workaround approaches.

Q2: What is the importance of patent family analysis?
A2: It reveals the geographical scope and potential global protection, influencing strategic licensing and enforcement options.

Q3: When should a company consider challenging the patent’s validity?
A3: When patent claims are overly broad, lack novelty, or are invalidated in prior art searches, challenging can weaken enforceability.

Q4: How does Slovenia’s patent landscape compare to the EU’s?
A4: Slovenia's patent system follows EU standards, but local enforcement is less influential than broader European or US protections for global strategies.

Q5: What are the risks of patent infringement in this space?
A5: Competitors may develop similar compounds or formulations outside patent claims’ scope, risking infringement challenges.


References

  1. European Patent Office. (2023). Guidelines for Examination. [online] Available at: https://www.epo.org/law-practice/legal-texts/guidelines.html
  2. World Intellectual Property Organization. (2020). Patent Landscape Reports. [online] Available at: https://www.wipo.int/patents/en/
  3. Slovenian Intellectual Property Office. (2023). Patent Law and Regulation. [online] Available at: https://www.uil-sipo.si/en/legislation

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.